Milano Furuta is the Corporate Strategy Officer and Chief of Staff of Takeda Pharmaceutical Company Ltd. He joined the company’s corporate strategy and business development team in 2010.
Mr. Furuta has held multiple international roles in several countries including Switzerland, Sweden and Mexico. His roles have included optimizing commercial organizations and launching products in the areas of oncology, diabetes, cardiovascular and metabolism.
Prior to joining Takeda, Mr. Furuta worked as an equity research analyst at an investment management firm in the United States. He began his career in banking and private equity investment in Japan, where he was involved with several types of financial transactions, including leveraged buyouts and debt restructuring.
Mr. Furuta holds an MBA from The Wharton School, University of Pennsylvania and a BA in international affairs from Hitotsubashi University, Japan.
Mr. Furuta lives in Tokyo with his wife and children.